The role of BRAFV600E mutation in a cohort of DTC with a long term follow-up is described and discussed
BRAFV600E mutation is an indipendent bad prognostic factor for the out come of patients with papillary thyroid carcinoma: a 15-year median follow-up study.
VIOLA, DAVID;Ugolini, Clara;BIAGINI, AGNESE;GIANNINI, RICCARDO;ROMEI, CRISTINA;MICCOLI, PAOLO;PINCHERA, ALDO;BASOLO, FULVIO;ELISEI, ROSSELLA
2007-01-01
Abstract
The role of BRAFV600E mutation in a cohort of DTC with a long term follow-up is described and discussedFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
